Pfizer Inc.: PharmaVitae Profile now available at ReportsandReports

Dallas, TX: ReportsandReports announce Pfizer Inc.: PharmaVitae Profile
Market Research Report in its Store.
Browse complete Report at : http://www.reportsandreports.com/reports/8182-pfizer-inc-pharmavitae-profile.html
This analysis examines the historical and forecast performance for Pfizer in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.

Reasons to Purchase
• Benchmark Pfizer’s performance against key rivals in the prescription pharmaceutical sector
• Assess how Pfizer’s M&A driven growth strategy will impact the company’s commercial performance through to 2015
• Analyze the impact of patent expiry for Pfizer’s flagship product Lipitor
• Table Of Contents
• ABOUT DATAMONITOR HEALTHCARE 2
About the PharmaVitae team 2
• Chapter 1 About this profile 3
PharmaVitae Explorer database 3
Chapter structure 3
Executive summary 3
Quarterly update 3
Company introduction 3
Company sales 4
Company financials 4
Key products 4
Data sourcing 4
Sales data 4
Analyst consensus 4
• Chapter 2 Executive summary 5
Key findings 5
Prescription pharmaceutical sales and growth rate performance, 2003-15 6
Financial performance, 2003-15 7
Pfizer: PharmaVitae forecasts at a glance 8
Strategic insight 9
Wyeth acquisition the latest in a succession of large scale M&A ‘plays’ by Pfizer 9
Diversification strategy at heart of Wyeth M&A 11
Outlook – will Pfizer return to the M&A trail before 2015? 16
SWOT analysis 19
Table of Contents 20
Table of figures 22
• Chapter 3 Quarterly news update 23
Latest quarterly sales 23
Latest comment 24
Hope for an Alzheimer’s breakthrough remains despite Dimebon’s failure 24
Pfizer’s novel NGF pain drug is potential game changer 25
Pfizer: Lyrica sNDA withdrawal no cause for anxiety 26
Latest prescription pharma product news 27
Q4 2009 29
Q3 2009 32
Q1 2009 33
Latest corporate news 35
Q1 2010 35
Q4 2009 35
Q3 2009 36
Q2 2009 36
Q1 2009 37
Future product milestones 39
• Chapter 4 Company introduction 41
Key findings 41
Background 42
Key corporate developments 42
M&A history 42
Warner-Lambert acquisition 43
Pharmacia acquisition 43
• Chapter 5 Company sales 46
Key findings 46
Prescription pharmaceutical sales and growth rate analysis, 2003-15 47
Product analysis 49
Product analysis, 2003-09 50
Product analysis, 2009-15 53
Therapy area analysis 56
Geographic analysis 59
Launch/core/expiry analysis 60
Explanation of launch/core/expiry analysis 60
Launch analysis, 2009-15 61
Core analysis, 2009-15 63
Expiry analysis, 2009-15 64
Launch/core/expiry configuration, 2009-15 66
Molecule type analysis 69
Externalization analysis 71
• Chapter 6 Company financials 73
Key findings 73
Reconciliation between PharmaVitae-formatted prescription pharma sales and company-reported total sales, 2002-08 74
Operating costs and profit analysis 75
Operating costs and profit analysis, 2002-08 76
Operating cost ratio and profit margin analysis, 2003-09 77
Operating cost ratio and profit margin analysis, 2009-15 78
Operating costs and profit analysis, 2009-15 79
• Chapter 7 Key products 81
Overview 81
Prevnar 82
Summary 82
Sales forecast 83
Enbrel 84
Summary 84
Sales forecast 85
Bapineuzumab 86
Summary 86
Sales forecast 87
Sutent 88
Summary 88
Sales forecast 89
Tygacil 90
Summary 90
Sales forecast 91
Lipitor 92
Summary 92
Sales forecast 93
Celebrex 94
Summary 94
Sales forecast 95
Viagra 96
Summary 96
Sales forecast 97
Xalatan/Xalacom 98
Summary 98
Sales forecast 99
Detrol/Detrol LA 100
Summary 100
Sales forecast 101
• Chapter 8 Appendix 103
Abbreviations 103
Exchange rates 104
About Datamonitor 105
About Datamonitor Healthcare 105
Datamonitor consulting 105
Disclaimer 107

Browse : Healthcare Market Research Reports
at : http://www.reportsandreports.com/cat/healthcare-market-research.html

Browse : Datamonitor Market Research Reports
at : http://www.reportsandreports.com/Publisher/datamonitor-market-research.html-market-research.html

Browse all Newly Published Market Research Reports
at :http://www.reportsandreports.com/LatestReport.aspx
Related Reports:
Browse all Forest Laboratories Inc.: PharmaVitae Profile
at : http://www.reportsandreports.com/reports/16328-forest-laboratories-inc-pharmavitae-profile.html
Browse all : Biogen Idec Inc.: PharmaVitae Profile
http://www.reportsandreports.com/reports/8538-biogen-idec-inc-pharmavitae-profile.html
Browse all : Watson Pharmaceuticals Inc.: PharmaVitae Profile
http://www.reportsandreports.com/reports/7449-watson-pharmaceuticals-inc-pharmavitae-profile.html
Browse all : Amgen Inc.: PharmaVitae Profile
http://www.reportsandreports.com/reports/8185-amgen-inc-pharmavitae-profile.html
Browse all : Alcon Inc.: PharmaVitae Profile
http://www.reportsandreports.com/reports/8517-alcon-inc-pharmavitae-profile.html
About Us:
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
Blog: http://reportsnreports.wordpress.com/
Blog: http://reportsandreports.blogspot.com/

Scroll to Top